Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02469584
Other study ID # 1236/2014
Secondary ID
Status Recruiting
Phase N/A
First received June 5, 2015
Last updated June 8, 2015
Start date October 2014
Est. completion date August 2015

Study information

Verified date June 2015
Source Medical University of Vienna
Contact Ksenia Halpern, Dr
Phone 00431404040029150
Email ksenia.halpern@meduniwien.ac.at
Is FDA regulated No
Health authority Austria: Agency for Health and Food Safety
Study type Interventional

Clinical Trial Summary

A descent of the anterior vaginal wall is the most common form of female pelvic organ prolapse (POP). Although anterior colporrhaphy (AC) is accepted worldwide as a "standard procedure", its exact steps are not well standardized.

We developed a small stitch anterior colporrhaphy (SSTAC) in an effort to increase the strength and durability of AC

Objectives

The aim of this pilot study is to demonstrate the feasibility and complication rate of the SSTAC and to assess the anatomical and functional outcomes after this method of cystocele repair.


Description:

A prospective case series evaluation of SSTAC following the recommendations of IDEAL-Collaboration (www.ideal-collaboration.net) will be performed. The newly developed procedure will be tested in a group of 10 patients, who equals stage 2a in the development and innovation of surgical innovations. In this stage safety and technical success is the main outcome. As technical modifications may be common during stage 2a and their nature and timing should be meticulously recorded, the videotaping during all surgical procedures will be performed.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date August 2015
Est. primary completion date August 2015
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- women older than 18 years of age

- Able to read, understand and sign informed consent

- symptomatic cystocele described as Points Aa or Ba >= 0 according to the International Continence Society pelvic organ prolapse quantification system (POP-Q)

Exclusion Criteria:

- previous urogynecological operation

- gynecologic malignancy

- planned concomitant incontinence operation

- other contraindications for surgery

- pregnancy

- systemic glucocorticoid treatment

- contraindication for the surgery

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
small stitch anterior colporrhaphy
A midline plication will be performed with continuous delayed absorbable sutures (3-0 polydioxanone) and the distance between the sutures will be 0.5 cm.

Locations

Country Name City State
Austria Medical University of Vienna Vienna

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary the most distal point of the anterior vaginal wall- postoperative anterior vaginal support described as Point Ba (POP-Q score) The changes in POPQ score preoperatively and three months after the anterior colporrhaphy with the new small stitch technic will be analyzed. 4-6 weeks, 3 months No
See also
  Status Clinical Trial Phase
Completed NCT02209337 - Demonstrate the Safety and Preformance of the SRS Device for the Treatment of Pelvic Organ Prolapse N/A
Completed NCT01393171 - Anterior Colporrhaphy Versus Cystocele Repair Using Polypropylene Mesh or Porcine Dermis N/A
Completed NCT00420225 - Mesh Repair of Anterior Vaginal Wall Prolapse Phase 3
Recruiting NCT06429228 - Comparison of 1 Versus 2 Days Post-Operative Catheterization After Anterior Colporrhaphy N/A